Lack of long-term benefits of a 6-month heart failure disease management program

Viviane Nguyen1, Anique Ducharme, Michel White

  • 1Montreal Heart Institute Research Center, Montreal, Quebec, Canada.

Insights

A 6-month heart failure management program (HFMP) showed initial benefits, but these effects on hospital readmissions and emergency visits did not last long-term. Further research on sustained HFMP is needed.

Area of Science:

  • Cardiology
  • Health Services Research

Background:

  • Heart failure (HF) is a significant healthcare burden, leading to frequent hospitalizations and emergency department (ED) visits.
  • Previous studies demonstrated short-term benefits of a multidisciplinary HF clinic, including reduced readmissions and improved quality of life.
  • The long-term sustainability of these benefits after program completion remained unclear.

Purpose of the Study:

  • To evaluate the long-term impact of a 6-month intensive heart failure management program (HFMP) on recurrent ED visits, hospital readmissions, and mortality.
  • To determine if the initial positive outcomes of the HFMP are maintained after the program's cessation.

Main Methods:

  • A retrospective analysis of 190 patients (New York Heart Association Class II-IV) initially randomized to a 6-month HFMP or standard care.
  • Long-term follow-up data (mean 2.8 years) was collected from Quebec administrative health databases.
  • Comparison of composite endpoints (all-cause death, hospital admissions, ED visits) and all-cause death between the HFMP and control groups.

Main Results:

  • No significant difference was observed in the composite endpoint of all-cause death, hospital admissions, and ED visits between the HFMP and control groups after a mean follow-up of 2.8 years.
  • Multivariable analysis confirmed no significant difference in the primary composite endpoint (HR 1.01) or all-cause death (HR 1.09) between groups.
  • The initial clinical and resource benefits of the 6-month HFMP were not sustained long-term.

Conclusions:

  • The benefits of a 6-month heart failure management program (HFMP) are not sustained once the program ends for severely ill patients.
  • Further investigation is necessary to explore the long-term efficacy and potential modifications of HFMP.
  • Long-term strategies are needed to maintain positive outcomes for heart failure patients post-program.
Abstract

Related Concept Videos

Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...